Adenosine: a prototherapeutic concept in neurodegeneration.
作者信息
von Lubitz D K, Carter M F, Beenhakker M, Lin R C, Jacobson K A
机构信息
Laboratory of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases/NIH, Bethesda, Maryland 20892, USA.
出版信息
Ann N Y Acad Sci. 1995 Sep 15;765:163-78; discussion 196-7. doi: 10.1111/j.1749-6632.1995.tb16573.x.
Abstract
摘要
相似文献
1
Adenosine: a prototherapeutic concept in neurodegeneration.腺苷：神经退行性变中的一种原治疗概念。
Ann N Y Acad Sci. 1995 Sep 15;765:163-78; discussion 196-7. doi: 10.1111/j.1749-6632.1995.tb16573.x.
2
Unravelling adenosine's effects on stroke.揭示腺苷对中风的影响。
Mol Med Today. 2000 Feb;6(2):48. doi: 10.1016/s1357-4310(99)01652-4.
3
Adenosine A2A receptors and neuroprotection.腺苷A2A受体与神经保护作用
Ann N Y Acad Sci. 1997 Oct 15;825:30-48. doi: 10.1111/j.1749-6632.1997.tb48412.x.
4
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration.腺苷受体与脑部疾病：神经保护与神经退行性变
Biochim Biophys Acta. 2011 May;1808(5):1380-99. doi: 10.1016/j.bbamem.2010.12.001. Epub 2010 Dec 9.
5
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors.大麻二酚在新生小鼠缺氧缺血性脑损伤体外模型中的神经保护作用是通过 CB(2)和腺苷受体介导的。
Neurobiol Dis. 2010 Feb;37(2):434-40. doi: 10.1016/j.nbd.2009.10.023. Epub 2009 Nov 6.
6
Pharmacology of lazaroids and brain energy metabolism: a review.
Pharmacol Rev. 1997 Mar;49(1):99-136.
7
Cytokines and acute neurodegeneration.
Mol Psychiatry. 1997 Mar;2(2):120-1. doi: 10.1038/sj.mp.4000223.
8
What can adenosine neuromodulation do for neuroprotection?
Curr Drug Targets CNS Neurol Disord. 2005 Aug;4(4):325-9. doi: 10.2174/1568007054546090.
9
A dual role of adenosine A2A receptors in 3-nitropropionic acid-induced striatal lesions: implications for the neuroprotective potential of A2A antagonists.腺苷A2A受体在3-硝基丙酸诱导的纹状体损伤中的双重作用：对A2A拮抗剂神经保护潜力的影响
J Neurosci. 2003 Jun 15;23(12):5361-9. doi: 10.1523/JNEUROSCI.23-12-05361.2003.
10
[Comparative characteristics of A1-receptor agonists as neuroprotective agents].
Eksp Klin Farmakol. 2001 Sep-Oct;64(5):19-22.
引用本文的文献
1
Enhancing neurogenesis after traumatic brain injury: The role of adenosine kinase inhibition in promoting neuronal survival and differentiation.增强创伤性脑损伤后的神经发生：腺苷激酶抑制在促进神经元存活和分化中的作用。
Exp Neurol. 2024 Nov;381:114930. doi: 10.1016/j.expneurol.2024.114930. Epub 2024 Aug 21.
2
Adenosine A1R/A3R agonist AST-004 reduces brain infarction in mouse and rat models of acute ischemic stroke.腺苷A1R/A3R激动剂AST-004可减少急性缺血性中风小鼠和大鼠模型中的脑梗死。
Front Stroke. 2022;1. doi: 10.3389/fstro.2022.1010928. Epub 2022 Nov 22.
3
Purinoceptors in the Central Nervous System.中枢神经系统中的嘌呤受体。
Drug Dev Res. 1996 Nov-Dec;39(3-4):361-370. doi: 10.1002/(sici)1098-2299(199611/12)39:3/4<361::aid-ddr17>3.0.co;2-4.
4
Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.腺苷激酶是预防缺血性神经元死亡的一个新的治疗靶点。
Open Drug Discov J. 2010 Jan 1;2(3):108-118.
5
6
Protection against ischemic damage by adenosine amine congener, a potent and selective adenosine A1 receptor agonist.腺苷胺类似物（一种强效且选择性的腺苷A1受体激动剂）对缺血性损伤的保护作用。
Eur J Pharmacol. 1999 Mar 26;369(3):313-7. doi: 10.1016/s0014-2999(99)00073-4.
7
Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.腺苷A1受体激动剂作为治疗缺血性脑疾病的临床可行药物。
Ann N Y Acad Sci. 1997 Oct 15;825:23-9. doi: 10.1111/j.1749-6632.1997.tb48411.x.
8
Modulation of apoptosis by adenosine in the central nervous system: a possible role for the A3 receptor. Pathophysiological significance and therapeutic implications for neurodegenerative disorders.腺苷对中枢神经系统细胞凋亡的调节作用：A3受体的潜在作用。对神经退行性疾病的病理生理意义及治疗启示。
Ann N Y Acad Sci. 1997 Oct 15;825:11-22. doi: 10.1111/j.1749-6632.1997.tb48410.x.
9
Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.沙土鼠脑缺血：腺苷A2A受体激动剂和拮抗剂的急性及慢性治疗效果
Eur J Pharmacol. 1995 Dec 20;287(3):295-302. doi: 10.1016/0014-2999(95)00498-x.
10
Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils.腺苷胺类似物（ADAC）缺血后给药：沙土鼠恢复情况分析
Eur J Pharmacol. 1996 Dec 5;316(2-3):171-9. doi: 10.1016/s0014-2999(96)00667-x.
本文引用的文献
1
Species Differences in Ligand Affinity at Central A-Adenosine Receptors.中枢A1-腺苷受体配体亲和力的种属差异。
Drug Dev Res. 1994 Sep;33(1):51-59. doi: 10.1002/ddr.430330109.
2
THE AGGREGATION OF BLOOD PLATELETS.血小板的聚集
J Physiol. 1963 Aug;168(1):178-95. doi: 10.1113/jphysiol.1963.sp007185.
3
Endogenous adenosine delays the onset of hypoxic depolarization in the rat hippocampus in vitro via an action at A1 receptors.内源性腺苷通过作用于A1受体，在体外延迟大鼠海马体中缺氧去极化的发生。
Brain Res. 1993 Apr 23;609(1-2):313-5. doi: 10.1016/0006-8993(93)90888-t.
4
Adenosine A2a receptor modulation of electrically evoked endogenous GABA release from slices of rat globus pallidus.腺苷A2a受体对大鼠苍白球切片电诱发内源性γ-氨基丁酸释放的调节作用
J Neurochem. 1993 Jun;60(6):2334-7. doi: 10.1111/j.1471-4159.1993.tb03526.x.
5
Adenosine A2a receptors in the nucleus accumbens mediate locomotor depression.伏隔核中的腺苷A2a受体介导运动抑制。
Brain Res Bull. 1993;31(3-4):397-404. doi: 10.1016/0361-9230(93)90233-2.
6
Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes.腺苷A2受体激动剂和GTP类似物对大鼠新纹状体膜中多巴胺D2受体调节的相反作用。
Eur J Pharmacol. 1993 Feb 15;244(3):311-5. doi: 10.1016/0922-4106(93)90157-5.
7
The A3 adenosine receptor is the unique adenosine receptor which facilitates release of allergic mediators in mast cells.A3 腺苷受体是唯一能促进肥大细胞释放过敏介质的腺苷受体。
J Biol Chem. 1993 Aug 15;268(23):16887-90.
8
Long-term caffeine treatment leads to a decreased susceptibility to NMDA-induced clonic seizures in mice without changes in adenosine A1 receptor number.长期咖啡因治疗可使小鼠对N-甲基-D-天冬氨酸（NMDA）诱导的阵挛性癫痫的易感性降低，而腺苷A1受体数量无变化。
Brain Res. 1993 May 28;612(1-2):271-7. doi: 10.1016/0006-8993(93)91672-f.
9
Propentofylline and other adenosine transport inhibitors increase the efflux of adenosine following electrical or metabolic stimulation of rat hippocampal slices.丙戊茶碱和其他腺苷转运抑制剂在对大鼠海马切片进行电刺激或代谢刺激后会增加腺苷的外流。
J Neurochem. 1994 Feb;62(2):563-73. doi: 10.1046/j.1471-4159.1994.62020563.x.
10
Effects of chronic administration of adenosine A1 receptor agonist and antagonist on spatial learning and memory.慢性给予腺苷A1受体激动剂和拮抗剂对空间学习与记忆的影响。
Eur J Pharmacol. 1993 Nov 16;249(3):271-80. doi: 10.1016/0014-2999(93)90522-j.
Zotero 插件